Gene · 9134
Papers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,792
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers. | Cancer Res | 2023 | 37384539 | PubTator, text mining | PubMed |
| Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities. | Front Mol Neurosci | 2023 | 37383425 | PubTator, text mining | PubMed |
| Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. | Int J Mol Sci | 2023 | 37373139 | PubTator, text mining | PubMed |
| Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers. | Biology (Basel) | 2023 | 37372161 | PubTator, text mining | PubMed |
| Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis. | Cancers (Basel) | 2023 | 37370847 | PubTator, text mining | PubMed |
| Correction: Dehydrodiisoeugenol inhibits colorectal cancer growth by endoplasmic reticulum stress-induced autophagic pathways. | J Exp Clin Cancer Res | 2023 | 37355608 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| The role of microRNAs in nicotine signaling. | EXCLI J | 2023 | 37346805 | PubTator, text mining | PubMed |
| Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A. | Front Bioeng Biotechnol | 2023 | 37346791 | PubTator, text mining | PubMed |
| Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity. | Cancers (Basel) | 2023 | 37345142 | PubTator, text mining | PubMed |
| WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells. | Cancers (Basel) | 2023 | 37345102 | PubTator, text mining | PubMed |
| TCGA Expression Analyses of 10 Carcinoma Types Reveal Clinically Significant Racial Differences. | Cancers (Basel) | 2023 | 37345032 | PubTator, text mining | PubMed |
| Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. | J Transl Med | 2023 | 37344841 | PubTator, text mining | PubMed |
| Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities. | Front Oncol | 2023 | 37342192 | PubTator, text mining | PubMed |
| Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases. | Int J Nanomedicine | 2023 | 37337578 | PubTator, text mining | PubMed |
| ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion. | Nat Commun | 2023 | 37336885 | PubTator, text mining | PubMed |
| KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification. | Aging (Albany NY) | 2023 | 37310408 | PubTator, text mining | PubMed |
| Pro-Apoptotic Activity and Cell Cycle Arrest of Caulerpa sertularioides against SKLU-1 Cancer Cell in 2D and 3D Cultures. | Molecules | 2023 | 37298837 | PubTator, text mining | PubMed |
| MicroRNA Regulation in Infectious Diseases and Its Potential as a Biosensor in Future Aquaculture Industry: A Review. | Molecules | 2023 | 37298833 | PubTator, text mining | PubMed |
| Spatio-temporal transcriptome dynamics coordinate rapid transition of core crop functions in 'lactating' pigeon. | PLoS Genet | 2023 | 37289658 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9134/papers?page=11